7 months ago
3
The manufacturing licence of Tamil Nadu based Sresan Pharmaceutical institution progressive successful making the adulterated cough syrup Coldrif has wholly been revoked, and the institution has been ordered to unopen down, the State authorities informed connected Monday (October 13, 2025).
The State Drug Control Department officials had during an inspection recovered the cough syrup contained 48.6% of Diethylene Glycol (DEG), a toxic substance. This medicine is linked to the decease of children successful Madhya Pradesh.
GROUND ZERO | Killer cough syrup
The officials had besides recovered that the institution lacked due bully manufacturing practices (GMP) and bully laboratory practices (GLP), and they recorded implicit 300 captious and large violations.
The company’s owner, G. Ranganathan, was precocious arrested by a peculiar probe squad from Madhya Pradesh.
Also Read | WHO seeks clarification from India if cough syrup has been exported to different countries
Earlier successful the day, a squad from the Enforcement Directorate searched the premises of Sresan Pharmaceuticals and immoderate officials, successful a Prevention of Money Laundering Act (PMLA) case.
“The cause manufacturing licence of Sresan Pharmaceuticals has been wholly cancelled, and the institution has been closed. Orders person been fixed to behaviour a elaborate inspection of different cause manufacturing companies located successful Tamil Nadu,” the authorities said.
